Depression Research and Treatment / 2011 / Article / Tab 2

Clinical Study

The Pharmacopsychometric Triangle to Illustrate the Effectiveness of T-PEMF Concomitant with Antidepressants in Treatment Resistant Patients: A Double-Blind, Randomised, Sham-Controlled Trial Revisited with Focus on the Patient-Reported Outcomes

Table 2

Side effects as total scores on UKU-24. LOCF analysis.

UKU-24Active T-PEMFSham T-PEMF
( )( )

Baseline12.3 (2.6)13.5 (2.3)
week 111.4 (3.4)12.2 (2.7)
week 210.0 (3.4)11.2 (2.9)
week 39.7 (3.1)11.1 (2.4)
week 49.0 (3.0)9.8 (2.1)
week 58.6 (3.8)10.2 (2.3)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.